New York City

(Image: iStock/Weedezign)

LabCorp to acquire Mount Sinai assets

By Melissa Fassbender

The asset acquisition adds seven patient service centers to LabCorps’ network of 120 patient service centers in the metropolitan New York City area.

People on the Move

People on the Move

People on the Move

By Fiona Barry

Former employees of Procter & Gamble, Merck & Co. and Bristol Myers Squibb have all found new homes in the pharma industry in this week's People column.

Big Pharmas to battle R&D bottlenecks

Big Pharmas team to tackle trial bottlenecks

The ten biggest drugmakers in the world want faster, more efficient R&D and claim a new non-profit organisation they formed last week is the solution to the industries development bottlenecks.

New York City: WRBM's new home in North America.

In-PharmaTechnologist.com’s publisher opens New York Office

By Mike Stones

William Reed Business Media, publisher of In-PharmaTechnologist.com, has opened an office in Lower Manhattan, New York City to re-enforce its position as the leading provider of independent news serving the US and global pharmaceutical industries.

New York: New York: WRBM's new North American home.

Outsourcing-Pharma.com’s publisher opens New York Office

By Mike Stones

William Reed Business Media, publisher of Outsourcing-Pharma.com, has opened an office in Lower Manhattan, New York City to re-enforce its position as the leading provider of independent news serving the US and global pharmaceutical outsourcing industries.

West to add CZ vials as glass QC issues drive interest

West to add CZ vials as glass QC issues drive interest

By Nick Taylor

Recognition of glass vial quality issues is supporting interest in West’s analytical capabilities and Crystal Zenith (CZ) products, new sizes of which are being developed, said a company VP.

IPT at Interphex 2010

IPT at Interphex 2010

By Claire Videau and Gareth Macdonald

Next week in-Pharmatechnologist heads for the excitement, energy and razamatazz of New York, US and Interphex 2010.

US state backs pharma

US state backs pharma

The US state of North Carolina has launched a new initiative aimed
at encouraging investment in the pharmaceutical and biotechnology
industries, with sizeable grants available to companies prepared to
invest $100 million or more in...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All